http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108283702-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-24 |
| filingDate | 2017-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108283702-B |
| titleOfInvention | A traditional Chinese medicine prescription for treating the sequelae of pelvic inflammatory disease |
| abstract | The invention discloses a traditional Chinese medicine prescription for treating the sequelae of pelvic inflammatory disease, and relates to the field of traditional Chinese medicine. It is prepared from raw materials containing the following weight ratios: Yuanhu, cooked rhubarb, raw Puhuang, fried Lingzhi, black medicine, wood incense, turmeric, white silkworm, cicada slough, fennel, and Achyranthes sichuanensis. The prescription of the invention has the functions of regulating qi, activating blood and relieving pain, and the formula is unique and refined, is used for the sequelae of pelvic inflammatory disease (chronic pelvic pain) caused by stagnation of qi and blood stasis, and is suitable for being developed into a new traditional Chinese medicine. |
| priorityDate | 2017-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.